New Tools in the Ebola Arsenal

As of September 23, investigational agents had been administered to 38 patients — MAb114 (22), remdesivir (9), and ZMapp (7). Nineteen of these patients had been discharged, 12 had died, and seven had remained hospitalized; those who died were in advanced stages of disease when treatment was initiated.

'This is a very dangerous outbreak': WHO chief 'worried' over Ebola in DRC, as experimental treatment begins

Some 100 armed groups are currently operating in North Kivu, which has seen over 120 violent incidents since January. A number of areas have been designated “red zones” – inaccessible areas where fighting is active.